SUSQUEHANNA INTERNATIONAL GROUP, LLP - SIGILON THERAPEUTICS INC ownership

SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 38 filers reported holding SIGILON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of SIGILON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$148,722
+325.1%
159,900
+60.0%
0.00%
Q4 2022$34,988
-39.7%
99,965
-13.1%
0.00%
Q3 2022$58,000
+5.5%
114,991
+75.1%
0.00%
Q2 2022$55,000
-22.5%
65,682
+36.7%
0.00%
Q1 2022$71,000
-85.7%
48,063
-73.2%
0.00%
Q4 2021$496,000
+63.7%
179,434
+234.0%
0.00%
Q3 2021$303,00053,7220.00%
Other shareholders
SIGILON THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 740,740$35,578,00013.90%
Flagship Pioneering Inc. 10,370,369$498,089,0009.07%
Monashee Investment Management LLC 561,628$26,975,0003.56%
SPHERA FUNDS MANAGEMENT LTD. 567,460$26,061,0002.31%
Avidity Partners Management LP 688,000$33,045,0001.07%
SECTORAL ASSET MANAGEMENT INC 225,000$10,807,0000.76%
Artal Group S.A. 276,000$13,256,0000.28%
GILDER GAGNON HOWE & CO LLC 662,227$31,807,0000.16%
CANADA PENSION PLAN INVESTMENT BOARD 1,485,185$71,333,0000.11%
Perceptive Advisors 125,000$6,004,0000.06%
View complete list of SIGILON THERAPEUTICS INC shareholders